BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20625150)

  • 1. Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
    Calvo E; Pastor FJ; Rodríguez MM; Pujol I; Guarro J
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4074-7. PubMed ID: 20625150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy against murine-disseminated infection by Fusarium verticillioides.
    Ruíz-Cendoya M; Pastor J; Guarro J
    Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
    Silva EG; Paula CR; de Assis Baroni F; Gambale W
    Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
    J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.
    Thomson P; Mayayo E; López-Fernández L; Guarro J; Capilla J
    Mycoses; 2017 Feb; 60(2):112-117. PubMed ID: 27696562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
    Pastor FJ; Ruíz-Cendoya M; Pujol I; Mayayo E; Sutton DA; Guarro J
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4550-5. PubMed ID: 20805397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of voriconazole in a murine model of invasive paecilomycosis.
    Rodríguez MM; Pastor FJ; Serena C; Guarro J
    Int J Antimicrob Agents; 2010 Apr; 35(4):362-5. PubMed ID: 20129763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
    Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
    J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
    de Castro Spadari C; da Silva de Bastiani FWM; Pisani PBB; de Azevedo Melo AS; Ishida K
    Arch Microbiol; 2020 May; 202(4):773-784. PubMed ID: 31832690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
    Takemoto K; Yamamoto Y; Ueda Y; Kanazawa K; Yoshida K; Niki Y
    Chemotherapy; 2009; 55(2):105-13. PubMed ID: 19151551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
    Barchiesi F; Spreghini E; Schimizzi AM; Maracci M; Giannini D; Carle F; Scalise G
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3312-6. PubMed ID: 15328090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis.
    Santos JR; César IC; Costa MC; Ribeiro NQ; Holanda RA; Ramos LH; Freitas GJ; Paixão TA; Pianetti GA; Santos DA
    Eur J Pharm Sci; 2016 Sep; 92():235-43. PubMed ID: 27235581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
    Fernández-Silva F; Capilla J; Mayayo E; Sutton DA; Hernández P; Guarro J
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6265-9. PubMed ID: 24100490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
    Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of triazoles in a murine disseminated infection by Candida krusei.
    Mariné M; Pastor FJ; Serena C; Guarro J
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3585-8. PubMed ID: 19470509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of voriconazole in experimental Cryptococcus neoformans infection.
    Mavrogiorgos N; Zaragoza O; Casadevall A; Nosanchuk JD
    Mycopathologia; 2006 Aug; 162(2):111-4. PubMed ID: 16897589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii.
    Mendes FE; Oliveira LV; Faria ES; Alvarenga DG; Pinto MR; Taborda CP; Soares BM; Cisalpino PS; Santos DA
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1525-32. PubMed ID: 20803047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.
    Chen SC; Korman TM; Slavin MA; Marriott D; Byth K; Bak N; Currie BJ; Hajkowicz K; Heath CH; Kidd S; McBride WJ; Meyer W; Murray R; Playford EG; Sorrell TC;
    Clin Infect Dis; 2013 Aug; 57(4):543-51. PubMed ID: 23697747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.